Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Enterobacteriaceae (FDR p= 0.012) and Akkermansia (FDR p= 0.015) being significant negative and positive predictors of neoadjuvant therapy response, respectively.
Murthy et al. 2022 J Clin Oncol 40: suppl 16 abstr 4143
Gut microbiota could serve as a biomarker of whether a neoadjuvant therapy of [PDAC](brain://BYLRSafMUEOtVrHkidXfJQ/…